Variant report
Variant | nsv970096 |
---|---|
Chromosome Location | chr6:28927690-28939080 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:174)
- CpG islands (count:122)
- Chromatin interactive region (count:15)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr6:28928928-28928962 | K562 | blood: | n/a | n/a |
2 | ATF1 | chr6:28933523-28933707 | K562 | blood: | n/a | n/a |
3 | ATF1 | chr6:28928793-28929120 | K562 | blood: | n/a | n/a |
4 | BACH1 | chr6:28928912-28929044 | K562 | blood: | n/a | n/a |
5 | BHLHE40 | chr6:28928828-28929147 | K562 | blood: | n/a | n/a |
6 | CBX3 | chr6:28927944-28929601 | K562 | blood: | n/a | n/a |
7 | CBX3 | chr6:28936470-28936863 | K562 | blood: | n/a | n/a |
8 | CBX3 | chr6:28936292-28937388 | K562 | blood: | n/a | n/a |
9 | CEBPB | chr6:28928854-28928861 | K562 | blood: | n/a | n/a |
10 | CEBPB | chr6:28939053-28939205 | HepG2 | liver: | n/a | n/a |
11 | CEBPD | chr6:28928620-28929126 | K562 | blood: | n/a | n/a |
12 | CHD2 | chr6:28928758-28929086 | K562 | blood: | n/a | n/a |
13 | CTCF | chr6:28936860-28937010 | BJ | skin: | n/a | n/a |
14 | CTCF | chr6:28936940-28937090 | A549 | lung: | n/a | n/a |
15 | CTCF | chr6:28937169-28937174 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | CTCF | chr6:28930400-28930439 | LNCaP | prostate: | n/a | n/a |
17 | CTCF | chr6:28936880-28937030 | HUVEC | blood vessel: | n/a | n/a |
18 | CTCF | chr6:28936980-28937130 | A549 | lung: | n/a | n/a |
19 | CTCF | chr6:28936880-28937030 | WI-38 | lung: | n/a | n/a |
20 | CTCF | chr6:28936980-28937130 | BE2_C | brain: | n/a | n/a |
21 | CTCF | chr6:28937000-28937150 | HRE | kidney: | n/a | n/a |
22 | CTCF | chr6:28936869-28937209 | H1-hESC | embryonic stem cell: | n/a | n/a |
23 | CTCF | chr6:28937060-28937210 | Hela-S3 | cervix: | n/a | n/a |
24 | CTCF | chr6:28936920-28937168 | H1-hESC | embryonic stem cell: | n/a | n/a |
25 | CTCF | chr6:28936980-28937130 | HVMF | connective: | n/a | n/a |
26 | CTCF | chr6:28937011-28937104 | A549 | lung: | n/a | n/a |
27 | CTCF | chr6:28936969-28937172 | Fibrobl | skin: | n/a | n/a |
28 | CTCF | chr6:28936940-28937090 | HPAF | blood vessel: | n/a | n/a |
29 | CTCF | chr6:28936966-28937122 | ProgFib | skin: | n/a | n/a |
30 | CTCF | chr6:28936960-28937110 | HBMEC | blood vessel: | n/a | n/a |
31 | CTCF | chr6:28936980-28937130 | SK-N-SH_RA | brain: | n/a | n/a |
32 | CTCF | chr6:28937039-28937046 | Gliobla | brain: | n/a | n/a |
33 | CTCF | chr6:28929290-28929341 | GM20000 | blood: | n/a | n/a |
34 | CTCF | chr6:28936960-28937110 | HepG2 | liver: | n/a | n/a |
35 | CTCF | chr6:28936992-28937133 | NHEK | skin: | n/a | n/a |
36 | CTCF | chr6:28936920-28937070 | HMF | breast: | n/a | n/a |
37 | CTCF | chr6:28936980-28937130 | HCPEpiC | choroid plexus: | n/a | n/a |
38 | CTCF | chr6:28936941-28937204 | H1-hESC | embryonic stem cell: | n/a | n/a |
39 | CTCF | chr6:28936963-28937121 | A549 | lung: | n/a | n/a |
40 | CTCF | chr6:28936900-28937050 | HFF-Myc | foreskin: | n/a | n/a |
41 | CTCF | chr6:28937008-28937116 | HUVEC | blood vessel: | n/a | n/a |
42 | CTCF | chr6:28929160-28929310 | HEK293 | kidney: | n/a | n/a |
43 | CTCF | chr6:28936960-28937110 | HMEC | breast: | n/a | n/a |
44 | CTCF | chr6:28936920-28937070 | HUVEC | blood vessel: | n/a | n/a |
45 | CTCF | chr6:28936896-28937157 | K562 | blood: | n/a | n/a |
46 | CTCF | chr6:28936997-28937135 | Hela-S3 | cervix: | n/a | n/a |
47 | CTCF | chr6:28936980-28937130 | SAEC | small airway: | n/a | n/a |
48 | CTCF | chr6:28937020-28937170 | WERI-Rb-1 | eye: | n/a | n/a |
49 | CTCF | chr6:28937044-28937095 | MCF-7 | breast: | n/a | n/a |
50 | CTCF | chr6:28937069-28937075 | Gliobla | brain: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:28937310-28937360 | HCF | heart: | n/a |
2 | chr6:28937310-28937360 | ProgFib | skin: | n/a |
3 | chr6:28937310-28937360 | RPTEC | kidney: | n/a |
4 | chr6:28938132-28938182 | NHBE | bronchial: | n/a |
5 | chr6:28937310-28937360 | AG04449 | skin: | fetal |
6 | chr6:28938132-28938182 | IMR90 | lung: | fetal |
7 | chr6:28938132-28938182 | SK-N-SH_RA | brain: | n/a |
8 | chr6:28937310-28937360 | BE2_C | brain: | n/a |
9 | chr6:28938132-28938182 | NHDF-neo | bronchial: | n/a |
10 | chr6:28938132-28938182 | HMEC | breast: | n/a |
11 | chr6:28938132-28938182 | AG04449 | skin: | fetal |
12 | chr6:28937310-28937360 | HepG2 | liver: | n/a |
13 | chr6:28937310-28937360 | NT2-D1 | testis: | n/a |
14 | chr6:28938132-28938182 | ECC-1 | luminal epithelium: | n/a |
15 | chr6:28937310-28937360 | AG09319 | gingival: | n/a |
16 | chr6:28937310-28937360 | HNPCEpiC | eye: | n/a |
17 | chr6:28937310-28937360 | ovcar-3 | ovarian: | n/a |
18 | chr6:28938132-28938182 | HCT-116 | colon: | n/a |
19 | chr6:28938132-28938182 | AoSMC | blood vessel: | n/a |
20 | chr6:28938132-28938182 | HCF | heart: | n/a |
21 | chr6:28938132-28938182 | LNCaP | prostate: | n/a |
22 | chr6:28937310-28937360 | CMK | blood: | n/a |
23 | chr6:28938132-28938182 | GM06990 | blood: | n/a |
24 | chr6:28938132-28938182 | HRPEpiC | eye: | n/a |
25 | chr6:28938132-28938182 | HRE | kidney: | n/a |
26 | chr6:28937310-28937360 | SK-N-MC | brain: | n/a |
27 | chr6:28938132-28938182 | H1-hESC | embryonic stem cell: | embryo |
28 | chr6:28937310-28937360 | U87 | brain: | n/a |
29 | chr6:28937310-28937360 | NHDF-neo | bronchial: | n/a |
30 | chr6:28938132-28938182 | HCPEpiC | choroid plexus: | n/a |
31 | chr6:28938132-28938182 | MCF-7 | breast: | n/a |
32 | chr6:28937310-28937360 | NH-A | brain: | n/a |
33 | chr6:28937310-28937360 | HRPEpiC | eye: | n/a |
34 | chr6:28938132-28938182 | K562 | blood: | n/a |
35 | chr6:28938132-28938182 | GM12878 | blood: | n/a |
36 | chr6:28938132-28938182 | RPTEC | kidney: | n/a |
37 | chr6:28937310-28937360 | MCF-7 | breast: | n/a |
38 | chr6:28937310-28937360 | AG10803 | skin: | n/a |
39 | chr6:28938132-28938182 | AG09309 | skin: | n/a |
40 | chr6:28938132-28938182 | Hela-S3 | cervix: | n/a |
41 | chr6:28937310-28937360 | AG04450 | lung: | fetal |
42 | chr6:28937310-28937360 | K562 | blood: | n/a |
43 | chr6:28938132-28938182 | ProgFib | skin: | n/a |
44 | chr6:28938132-28938182 | CMK | blood: | n/a |
45 | chr6:28937310-28937360 | Caco-2 | colon: | n/a |
46 | chr6:28938132-28938182 | GM19239 | blood: | n/a |
47 | chr6:28937310-28937360 | T-47D | breast: | n/a |
48 | chr6:28938132-28938182 | BE2_C | brain: | n/a |
49 | chr6:28937310-28937360 | SAEC | small airway: | n/a |
50 | chr6:28938132-28938182 | NB4 | blood: | n/a |
(count:15 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:28926644..28928664-chr6:28929682..28931207,2 | K562 | blood: | |
2 | chr6:28926004..28928309-chr6:28944355..28946221,2 | K562 | blood: | |
3 | chr6:28888002..28892936-chr6:28927795..28931066,4 | K562 | blood: | |
4 | chr6:28926644..28928664-chr6:28929682..28931207,2 | K562 | blood: | |
5 | chr6:28928142..28929743-chr6:28947588..28949383,2 | K562 | blood: | |
6 | chr6:28916396..28919032-chr6:28931395..28932899,2 | K562 | blood: | |
7 | chr6:28889372..28892274-chr6:28936954..28941148,4 | K562 | blood: | |
8 | chr6:28926644..28928695-chr6:28929682..28932327,2 | K562 | blood: | |
9 | chr6:28926644..28928695-chr6:28929682..28932327,2 | K562 | blood: | |
10 | chr6:28887886..28894013-chr6:28935014..28940220,8 | K562 | blood: | |
11 | chr6:28926035..28928870-chr6:28956157..28957921,2 | K562 | blood: | |
12 | chr6:28931535..28933777-chr6:28950543..28952333,2 | K562 | blood: | |
13 | chr6:28927503..28930873-chr6:28944812..28947350,3 | K562 | blood: | |
14 | chr6:28890252..28892936-chr6:28929297..28931066,2 | K562 | blood: | |
15 | chr6:28931828..28934323-chr6:28943068..28945762,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
KRT18P1 | TF binding region |
KRT18P1 | CpG island |
ENSG00000204713 | chromatin interactions |
ENSG00000263426 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs560751230 | chr6:28927719-28927720 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs574347776 | chr6:28927744-28927745 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs142970597 | chr6:28927749-28927750 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs68123503 | chr6:28927750-28927751 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs33959457 | chr6:28927751-28927752 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs543139844 | chr6:28927752-28927753 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs386487580 | chr6:28927753-28927754 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs540173587 | chr6:28927766-28927767 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs370219549 | chr6:28927774-28927775 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs564263606 | chr6:28927781-28927782 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs373973738 | chr6:28927833-28927834 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs7763905 | chr6:28927864-28927865 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs149249130 | chr6:28927868-28927869 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs562333102 | chr6:28927876-28927877 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs184269778 | chr6:28927908-28927909 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs563889279 | chr6:28927931-28927932 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs373251958 | chr6:28927932-28927933 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs188552195 | chr6:28927973-28927974 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs180919181 | chr6:28927991-28927992 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs370458524 | chr6:28928005-28928006 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs375729752 | chr6:28928009-28928010 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs567202688 | chr6:28928018-28928019 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs528092420 | chr6:28928020-28928021 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs539334371 | chr6:28928035-28928036 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs185905514 | chr6:28928049-28928050 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs569453513 | chr6:28928060-28928061 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs537961754 | chr6:28928062-28928063 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs554616003 | chr6:28928063-28928064 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs574359498 | chr6:28928083-28928084 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs540178903 | chr6:28928106-28928107 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs553484059 | chr6:28928111-28928112 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs576767564 | chr6:28928124-28928125 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs12386522 | chr6:28928167-28928168 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs562360154 | chr6:28928178-28928179 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs374243347 | chr6:28928197-28928198 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs144480264 | chr6:28928198-28928199 | Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs189169292 | chr6:28928206-28928207 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs137937474 | chr6:28928236-28928237 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs182568447 | chr6:28928244-28928245 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs368835890 | chr6:28928245-28928246 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs547015732 | chr6:28928278-28928279 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs187139040 | chr6:28928308-28928309 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs532884959 | chr6:28928324-28928325 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs190610466 | chr6:28928333-28928334 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs182786457 | chr6:28928335-28928336 | Weak transcription Enhancers Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs377654472 | chr6:28928418-28928419 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs142519937 | chr6:28928437-28928438 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs538401896 | chr6:28928465-28928466 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs372763052 | chr6:28928467-28928468 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs554369647 | chr6:28928485-28928486 | Enhancers Weak transcription Flanking Active TSS | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:28922200-28928400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr6:28922200-28930600 | Weak transcription | Right Atrium | heart |
3 | chr6:28923000-28928600 | Weak transcription | HepG2 | liver |
4 | chr6:28923400-28928600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr6:28923800-28928600 | Weak transcription | NHEK | skin |
6 | chr6:28927000-28928000 | Enhancers | K562 | blood |
7 | chr6:28928000-28929400 | Flanking Active TSS | K562 | blood |
8 | chr6:28928200-28929400 | Enhancers | Hela-S3 | cervix |
9 | chr6:28928400-28928800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr6:28928400-28929200 | Enhancers | Stomach Mucosa | stomach |
11 | chr6:28928600-28928800 | Enhancers | HepG2 | liver |
12 | chr6:28928600-28929000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
13 | chr6:28928600-28929000 | Enhancers | HMEC | breast |
14 | chr6:28928600-28929200 | Enhancers | NHEK | skin |
15 | chr6:28928800-28929200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
16 | chr6:28929000-28929400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
17 | chr6:28929400-28929600 | Enhancers | K562 | blood |
18 | chr6:28929600-28932800 | Weak transcription | K562 | blood |
19 | chr6:28932800-28933600 | Enhancers | K562 | blood |
20 | chr6:28933600-28936000 | Weak transcription | K562 | blood |
21 | chr6:28936000-28936800 | ZNF genes & repeats | K562 | blood |
22 | chr6:28936800-28937800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
23 | chr6:28937800-28944800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
24 | chr6:28938400-28938800 | Enhancers | HepG2 | liver |
25 | chr6:28938800-28941800 | Weak transcription | HepG2 | liver |